Section Arrow
Quote
BCLI.NASDAQ
- Brainstorm Cell Therapeutics
(Financial Status)
Quotes are at least 15-min delayed:2024/12/24 12:20 EST
Last
 2.2091
+0.1391 (+6.72%)
Day High 
2.22 
Prev. Close
2.07 
1-M High
2.4499 
Volume 
38.36K 
Bid
2.2
Ask
2.21
Day Low
2.09 
Open
2.09 
1-M Low
1.2326 
Market Cap 
11.81M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.82 
20-SMA 1.72 
50-SMA 1.7 
52-W High 11.890485 
52-W Low 1.05 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.45/-1.52
Enterprise Value
12.48M
Balance Sheet
Book Value Per Share
-1.06
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.3949-0.0082-2.03%-- 
CMNDClearmind Medicine1.67+0.45+36.89%0.16PE
CEROCERo Therapeutics Holdings0.0594+0.0089+17.62%-- 
RXRXRecursion Pharmaceuticals7.2218+0.2318+3.32%-- 
CDTConduit Pharmaceuticals0.0601+0.0056+10.28%-- 
Quotes are at least 15-min delayed：2024/12/24 12:20 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.